<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sat, 14 Nov 2026 18:57:44 -0500--><rss version="2.0">
    <channel>
        <title>Dogwood Therapeutics, Inc. (DWTX) Press Releases</title>
        <link>https://ir.dwtx.com/news/press-releases/rss</link>
        <description>Please specify a description for this RSS Feed</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/_9f55823e9477de6aca19e5bcf0d048d4/virios/files/theme/images/DogwoodLogo.png</url>
                <title>Dogwood Therapeutics, Inc. Logo</title>
                <link></link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Dogwood Therapeutics Announces Third Quarter 2026 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/164/dogwood-therapeutics-announces-third-quarter-2026-financial</link>
                <pubDate>Thu, 05 Nov 26 08:30:00 -0500</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/164/dogwood-therapeutics-announces-third-quarter-2026-financial</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood Announces $5 Million Private Placement with CK Life Sciences Int’l., (Holdings) Inc.]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/163/dogwood-announces-5-million-private-placement-with-ck-life</link>
                <pubDate>Mon, 19 Oct 26 08:30:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/163/dogwood-announces-5-million-private-placement-with-ck-life</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood to Participate in the 2026 Maxim Growth Summit]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/162/dogwood-to-participate-in-the-2026-maxim-growth-summit</link>
                <pubDate>Tue, 06 Oct 26 08:45:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/162/dogwood-to-participate-in-the-2026-maxim-growth-summit</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood Announces Completion of Enrollment in Ongoing Halneuron® Phase 2b Trial]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/161/dogwood-announces-completion-of-enrollment-in-ongoing</link>
                <pubDate>Mon, 14 Sep 26 08:45:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/161/dogwood-announces-completion-of-enrollment-in-ongoing</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood to Host Virtual KOL Event to Discuss Halneuron® for the Treatment of Chemotherapy Induced Neuropathic Pain on September 1, 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/160/dogwood-to-host-virtual-kol-event-to-discuss-halneuron</link>
                <pubDate>Mon, 17 Aug 26 08:30:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/160/dogwood-to-host-virtual-kol-event-to-discuss-halneuron</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood Therapeutics Announces Second Quarter 2026 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/159/dogwood-therapeutics-announces-second-quarter-2026</link>
                <pubDate>Thu, 13 Aug 26 08:30:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/159/dogwood-therapeutics-announces-second-quarter-2026</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood Enrolls First 200 Patients in Ongoing Halneuron® Phase 2b Chemotherapy Induced Neuropathy Trial; Top-line Data Expected in Fall 2026]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/158/dogwood-enrolls-first-200-patients-in-ongoing-halneuron</link>
                <pubDate>Mon, 20 Jul 26 08:30:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/158/dogwood-enrolls-first-200-patients-in-ongoing-halneuron</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood Therapeutics Appoints Iain Dukes, Venture Partner at OrbiMed, as Chair of Scientific Advisory Board]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/157/dogwood-therapeutics-appoints-iain-dukes-venture-partner</link>
                <pubDate>Tue, 30 Jun 26 08:45:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/157/dogwood-therapeutics-appoints-iain-dukes-venture-partner</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood Therapeutics Announces Commencement of Halneuron® Chemotherapy Induced Neuropathic Pain Phase 2b Long Term Extension Study]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/156/dogwood-therapeutics-announces-commencement-of-halneuron</link>
                <pubDate>Mon, 18 May 26 08:45:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/156/dogwood-therapeutics-announces-commencement-of-halneuron</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Dogwood Therapeutics Announces First Quarter 2026 Financial Results]]></title>
                <description><![CDATA[]]></description>
                <link>https://ir.dwtx.com/news/press-releases/detail/155/dogwood-therapeutics-announces-first-quarter-2026-financial</link>
                <pubDate>Thu, 14 May 26 08:30:00 -0400</pubDate>
                <guid isPermalink="true">https://ir.dwtx.com/news/press-releases/detail/155/dogwood-therapeutics-announces-first-quarter-2026-financial</guid>
                                                                            </item>
            </channel>
</rss>